AP NEWS

$4.05 Bn Pancreatic Cancer Therapy Market to 2025 - Global Analysis and Forecasts By Type, Therapy and Geography - ResearchAndMarkets.com

September 21, 2018

DUBLIN--(BUSINESS WIRE)--Sep 21, 2018--The “Pancreatic Cancer Therapy Market to 2025 - Global Analysis and Forecasts By Type, Therapy and Geography” report has been added to ResearchAndMarkets.com’s offering.

The global pancreatic cancer therapy market is expected to reach US$ 4,056.4 Mn in 2025 from US$ 2,011.2 Mn in 2017. The market is estimated to grow with a CAGR of 8.1% from 2018-2025.

The growth of the pancreatic cancer therapy market is primarily attributed to the increase in number of therapies launched in the market. The development of new drugs is thus expected to drive the growth of pancreatic cancer therapy market. For instance, in October 2015, the FDA approved Onivyde drug by Merrimack Pharmaceuticals, Inc. as a part of treatment regimen for advanced pancreatic cancer. Some common side effects associated with chemotherapy drugs include diarrhea and abdominal cramping, fatigue, loss of appetite, change in food taste and others. Cancer cells that are rapidly growing are killed by chemotherapy drugs.However, these drugs travel throughout the body and thus can affect normal and healthy cells adversely. Blood-forming cells in the bone marrow, hair follicles and cell in the mouth, digestive tract, and reproductive system are likely to be affected by chemotherapeutic drugs. The current treatment options available for pancreatic cancer patients only help to extend the patients’ lives by a few months. This demands potential drugs that are able to enhance the effectiveness of chemotherapy drugs. Combination of two or more chemotherapy drugs are a suitable way out to increase the efficacy of the drug as well as proves advantageous in the treatment.

Key Topics Covered:

1. Introduction

2. Global Pancreatic Cancer Therapy Market - Key Takeaways

3. Global Pancreatic Cancer Therapy Market - Market Landscape

4. Global Pancreatic Cancer Therapy Market - Key Market Dynamics

5. Pancreatic Cancer Therapy Market - Global Analysis

6. Pancreatic Cancer Therapy Market Analysis- by Type

7. Global Pancreatic Cancer Therapy Market Analysis- by Therapy

8. North America Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025

9. Europe Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025

10. Asia Pacific Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025

11. Middle East and Africa Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025

12. South and Central America Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025

13. Pancreatic Cancer Therapy Market - Industry Landscape

14. Pancreatic Cancer Therapy Market - Key Company Profiles

Eli Lilly and CompanyF. Hoffmann-La Roche AGCelgene CorporationAmgen Inc.Novartis AGPharmacyte Biotech Inc.Clovis OncologyTeva Pharmaceutical Industries Ltd.Pfizer Inc.Merck & Co., Inc.For more information about this report visit https://www.researchandmarkets.com/research/c9cmqs/4_05_bn?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180921005224/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pancreatic Cancer Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/21/2018 07:58 AM/DISC: 09/21/2018 07:58 AM

http://www.businesswire.com/news/home/20180921005224/en

AP RADIO
Update hourly